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Three-Dimensional 1060-nm OCT: Choroidal Thickness
Maps in Normal Subjects and Improved Posterior
Segment Visualization in Cataract Patients
Marieh Esmaeelpour,1 Boris Povazˇay,1,2 Boris Hermann,1,2 Bernd Hofer,1,2 Vedran Kajic,1
Ketan Kapoor,1 Nik J. L. Sheen,1 Rachel V. North,1 and Wolfgang Drexler1,2
PURPOSE. To evaluate the performance and potential clinical role
of three-dimensional (3D) 1060-nm OCT by generating choroidal
thickness (ChT) maps in patients of different ages with different
degrees of ametropia and axial lengths and to investigate the
effect of cataract grade on OCT retinal imaging quality.
METHODS. Axial lengths (ALs) and 45° fundus photographs were
acquired from 64 eyes (34 healthy subjects, 19 to 80 years,
ametropia 3 to 10 D). 3D 1060-nm OCT was performed over
a 36°  36° field of view with 7-m axial resolution and up to
70 frames/s (512 A-scans/frame). ChT maps between retinal pig-
ment epithelium and the choroidal–scleral interface, were gener-
ated and statistically analyzed. A further 30 eyes (19 subjects),
with cataracts assessed with the LOCS III scale, were imaged with
3D 1060-nm OCT and 800-nm OCT, and visualization of the
posterior segment was compared qualitatively.
RESULTS. In 64 eyes, ChT maps displayed a thickness decrease
with increasing AL. Subfoveal ChT was 315  106 m (mean 
SD), negatively correlated with AL (R2  0.47, P  0.001).
Averaged ChT maps of eyes with AL  23.39 mm showed an
increased ChT in an area 1500 m inferior, compared with
subfoveal ChT. Eyes with AL 24.5 mm showed a larger variation
and a thicker ChT superiorly than inferiorly. Reduced signal
strength in cataractous eyes was found in 65% of the 800-nm OCT
images, but in only 10% of the 1060-nm OCT images.
CONCLUSIONS. The imaging performance of 3D 1060-nm OCT is
unique, producing maps that show the variation in ChT over
the entire field of view, in relation to axial length. This imaging
system has the potential of visualizing a novel clinical diagnos-
tic biomarker. Compared with 800-nm OCT, it provides supe-
rior visualization of the posterior pole in cataractous eyes.
(Invest Ophthalmol Vis Sci. 2010;51:5260–5266) DOI:
10.1167/iovs.10-5196
High-resolution, high-speed, three-dimensional optical co-herence tomography at 1060 nm (3D 1060-nm OCT) im-
ages the retina and, in contrast to OCT at 800 nm, significantly
increases choroidal penetration,1–6 with less light-scattering by
cataract.2 Previously, in vivo investigation of the choroid has
been possible with ultrasound and MRI, but with limited res-
olution.7,8 Histology of choroidal thickness (ChT) reveals in-
creased ChT that correlates with a higher density of vessels in
the superficial choroidal layers in open-angle glaucoma,9 atro-
phy of the choroidal capillary structure,10 and neovasculariza-
tion in the choriocapillaris.11,12 Histologic studies investigated
biological structures with comparable high resolution, but
these were limited by preparation artifacts, shrinkage, and lack
of blood supply to sustain vasculature volume.13 Commercial
OCT systems operating at 800 nm have shown choroidal pen-
etration only in thin choroids of myopic subjects, or by imag-
ing limited to two-dimensional (2D) horizontal scans.14–16 The
clinical value of imaging the choroid has been shown in a small
sample of patients, by using OCT at 1060 nm to demonstrate
ChT variation over the field of view in uveal inflammation17
and to demonstrate an increase in vessel density at the center
of choroidal neovascularization in age-related macular degen-
eration (ARMD).2,18 Recent interest in the choroid led to a
study in which 3D 1060-nm OCT was used to investigate ChT
confined to central and four peripheral measurement locations
in a healthy Japanese population.19 However, analyzing the
measurements at several image locations neglects the remain-
ing data collected over the entire imaged field. ChT changes
may occur in patients with diabetes or ARMD, and both these
groups have a high incidence of cataract. With the current
commercial OCT systems that work at 800 nm, cataract may
reduce imaging quality or make image acquisition unsuccess-
ful.20 In contrast to OCT at 800 nm, light is less scattered by
cataract when OCT at 1060 nm is used,2 but it is not clear
whether visualizing the ChT with a 3D 1060-nm OCT can be
successful in eyes with dense cataract.
In two separate studies, we explored the performance of
OCT at 1060 nm, to penetrate the highly light-scattering cho-
roid. The first study of choroidal visualization performance was
conducted to quantify the complete 3D 1060-nm OCT scan
with ChT maps and to investigate the ChT maps in healthy
subjects across a wide range of ametropia and axial eye length
(AL). The second is a study of 3D 1060-nm OCT performance
in the presence of dense cataracts to determine retinal and
choroidal visibility where the 800-nm OCT fails.
METHODS
Subjects for ChT Maps
Thirty-four healthy male and female subjects between the ages of 19
and 80 years participated (Table 1). Exclusion criteria were a history of
retinal surgery, retinal disease; physiological variation from normal,
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such as drusen, epiretinal membranes, or central retinal degeneration;
or systemic disease, such as diabetes mellitus. After the application of
these criteria, 64 eyes were included in the choroidal study. Monocular
visual acuity was determined with the ETDRS Original Series Charts
(Precision Vision, La Salle, IL). All subjects had visual acuity ranging
between 0.1 and 0.3 logMAR, and all imaging was conducted
without pupil dilation. The refractive error was measured with an
autorefractometer (KR-7500; Topcon, Tokyo, Japan).
OCT Imaging in Cataractous Eyes
Thirty eyes of 19 subjects (Table 1) with cataract were graded in vivo
at the slit lamp, according to the Lens Opacities Classification System
III (LOCS III).21 LOCS III categorizes lens opacification into nuclear
color (NC), nuclear opacity (NO), cortical cataract (C), and posterior
subcapsular cataract (P). It applies photographic standards to grade
cataract severity on a decimal scale between 0.1 and 6 units for NC and
NO, and 0.1 and 5.9 units for C and P. In this study, exclusion criteria
were pseudoaphakia and any cataract with an LOCS III scale of 1
unit. Cataractous eyes with opacification in multiple classifications
were chosen to evaluate the consistency of image quality in a wide
range of overall cataract density, regardless of classification.
Ethics approval was obtained from the School of Optometry and
Vision Sciences, Cardiff University Ethics Committee, and the Central
and Local Office for Research Ethics Committees. The studies adhered
to the Declaration of Helsinki, and informed consent was obtained
from all subjects before participation.
OCT Imaging and Ocular Biometry for ChT Maps
Retinal status was evaluated with a fundus photograph with a 45° field
centered on the macula, taken with a nonmydriatic retinal camera
(CR-DGi; Canon, Inc. Lake Success, NY). Five AL (cornea-RPE) mea-
surements were averaged from each eye by optical biometry (IOL
Master; Carl Zeiss Meditec, Jena, Germany). High-speed 3D OCT-imag-
ing at 1060 nm was performed with less than 2.5 mW at the cornea,
well below the maximum power limit for a 10-second exposure.22,23
Three-dimensional (3D) OCT volumes were acquired at 1060 nm with
15 to 20 m transverse resolution, 7 m axial resolution, and 512
voxels per depth scan (A-scan). Scans across a 36°  36° field and an
18°  18° field with 512  512 A-scans at 47,000 A-scans/s were
centered on the fovea and produced up to 70 frames/s. For image
processing and manual measurement of pixel distances in the choroid
and retina, ImageJ software24 was used.
OCT Imaging for the Cataract Eyes
Subjects were imaged with 1060-nm OCT as described previously, all
eyes were additionally imaged with an 800-nm OCT (Cirrus HD-OCT;
Carl Zeiss Meditec). System specifications of both OCT instruments
(800 nm and 1060 nm), such as 97-dB signal-to-noise ratio and their
roll-off with scanning depth of 6 dB at 1.1 mm, 6- to 7-m axial
resolution, and 2.6-mm scanning depth were comparable and thus
allowed an objective and fair comparison of the wavelength effect on
posterior pole visualization performance. Imaging was performed over
a field of view of 20° centered around the fovea with 512  512
A-scans and 128 B-scans.
Data Analysis for ChT Maps
For ChT maps, a field of 36° 36° scans with each degree correspond-
ing to 288 m,25 was centered on the fovea. The OCT volume was
averaged in both transverse directions within a field of 1°, to remove
speckle and increase sensitivity. Axial ChT was defined as the distance
between the center of the peaks originating from the RPE/Bruch’s
membrane/choriocapillaris (RBC) complex26 and the choroid–sclera
interface (CSI). For the investigation of the ChT variation throughout
the entire field of view, thickness maps were generated based on
manual segmentation, with segmentation in every fourth tomogram at
the RBC complex and the CSI. Two-dimensional ChT maps, generated
by local subtraction of the segmented height profiles were smoothed
by transverse filtering and splining between the slices, followed by a
final 2D median filter with a 15  15 kernel size. The resulting pixel
FIGURE 1. Images generated from the 1060-nm OCT stack. (a) En face
view (generated by integrated OCT 3D stack in depth) depicting the
ONH and the fovea. , locations of the thickness measurements:
central (C), superior (S), nasal (N), inferior (I), temporal (T).
(b) Overview of a central cross-section indicates the locations of the T,
C, and N measurement distances. Dashed lines: sections magnified in
(c, d, e); pink arrows: ChT measurement.
TABLE 1. Demographic and Statistical Data of the Cohort
Mean  SD Range
Healthy eyes for ChT map
study (n  64)
Axial length and range, mm 24.21  1.9 22 to 32
Spherical equivalent of
refraction, DS 1.07  3.10 3.00 to 10.00
Age, y 42  17 19 to 80
Sex
Women, 30 eyes
Men, 34 eyes
Eyes with cataract (n  30)
Age, y 70  9 50 to 90
Sex
Women, 7 eyes
Men, 23 eyes
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distance was converted into optical distance by using the depth sam-
pling calibration for the 1060-nm OCT system and to physiological
distance by using a group refractive index of n  1.4 (based on the
refractive index of blood). This method resulted in thickness maps for
individual eyes. For statistical analysis of the mean and variation of the
ChT maps of individuals with similar ametropia, all the maps were
aligned with one another with respect to the macula and optic nerve
position (MatLab software; The MathWorks, Inc., Natick, MA). After
correcting for differences in transverse area size with AL, an intensity
overlay was introduced to exclude unreliable portions of the images
with less than five measurements at one location. The images were
evaluated along the depth-scan direction. ChT maps were grouped by
judging the eyes’ refraction to be myopic (AL  24.5 mm; n  16),
emmetropic (24.5 AL 23.4 mm, n 20), or hyperopic (AL 23.4
mm; n  28), on the basis of normal AL variation with refraction and
age in the literature.27–29 Groups are described as characteristically
myopic (long ALs), emmetropic (mid length eyes), and hyperopic
(short eyes). Mean and SD was obtained to create a compound map of
average thickness for these three groups of eyes with color-coded
thickness.
For statistical assessment of individual variation between eyes,
central ChT was located for the choroid beneath the fovea. Peripheral
ChT was determined for the nasal, temporal, superior, and inferior
choroid at a distance of 7.5° to the foveal center (Fig. 1) Statistical
testing for normally distributed data and adjustments so that outliers
did not affect the statistical outcomes were performed. Multiple re-
gression analysis was performed to assess the influence of ametropia,
AL, age, and sex on ChT at five different choroid locations (SPSS 16;
SPSS, Inc., Chicago, IL).
Data Analysis for Images in Cataractous Eyes
The same processing protocol was used for images of the choroid
taken by both OCT devices in the cataract study. To keep the compar-
ison of the en face views similar, we did not include the imaged
choroid when generating en face images averaged between the RPE
and the ILM. One investigator, blind to the type of OCT used, assessed
imaging performance in tomograms acquired with both wavelengths
by searching for noticeable changes in contrast, localized signal
strength decrease, blurring within en face views, and tomograms of
eyes with cataracts and compared it to that in images of eyes without
cataract in the healthy study group.
RESULTS
ChT Maps
For the 64 healthy eyes, all tomograms were of sufficient
quality to allow ChT measurement. Although the eyes were not
dilated, image signal in the 36°  36° scans was acquired in a
field of at least 30°.
ChT maps (Fig. 2) show mean ChT distribution and the
coefficient of variation over the imaged field of view. Hyper-
opic eyes had a central ChT of 358  96 m (mean  SD) and
had the thickest choroid inferiorly but still within a 1500-m
distance from the center. Emmetropic eyes had a ChT of 341
95 m, whereas myopic eyes had the thinnest choroid of the
three groups, with a central ChT of 213  58 m (P  0.001,
ANOVA, Bonferroni post hoc testing) and an increase of thick-
ness approximately 1500 m superior to the center. For illus-
trating the location and extent of variation in the data sets, we
found the coefficient of variation useful in making comparisons
of widely different means. The coefficient of variation is ex-
pressed as a percentage of the standard deviation from the
mean. The coefficient of variation was lowest in hyperopic
eyes, less than 30% over most of the ChT map. In emmetropes,
the areas that had this low variation were smaller, and in
myopes the predominant coefficient of variation was between
30% and 45%.
Results of the regression analysis for each of the three
groups showed that only the ChT in myopes correlated signif-
icantly with age and AL, depending on the location measured
(Table 2). In emmetropic eyes, the ChT variation could not be
statistically explained by the factors that we examined. The
temporal ChT in hyperopic eyes weakly but significantly cor-
related with AL. For all eyes, the mean  SD of ChTs were
315  106 m (C), 250  113 m (N), 276  95 m (T),
315  112 m (S), and 293  106 m (I). ALs correlated
negatively with ChTs for all five transverse locations (Fig. 3;
Table 2). Regression analysis of all 64 eyes found no relation-
ship for age and sex (P 0.05). The spherical equivalent of the
prescription also correlated with ChT (R2  0.29 P  0.05),
with hyperopic eyes having the thickest and myopic eyes the
thinnest choroid. However, since AL and ametropia are two
correlating factors, the refractive error was excluded because
of its colinearity with AL.
FIGURE 2. ChT maps, grouped by ax-
ial length, to distinguish the degree of
ametropia (hyperopic, short eyes:
AL 23.4 mm; emmetropic midlength
eyes: 24.5 mm  AL  23.4 mm and
myopic long eyes: AL  24.5 mm). ,
the fovea. (a–c) Mean ChT was highest
in hyperopes, and its distribution
throughout the posterior eye differed
between groups. (d–f) Coefficients of
variation showed areas of variation be-
low 30% to be largest in the hyperope
group and to decrease in myopes.
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3D 1060-nm OCT Performance in Cataract Eyes
For the subjects with cataracts, the mean visual acuity was
0.22  0.21 log units. LOCS classification and grades for all
eyes and eyes grouped by OCT device and image quality are
shown in Table 3. In 30 eyes, cataract image quality was
reduced in 13 (65%) imaged at 800 nm and in 3 (10%) imaged
at 1060 nm. The decreased image quality was observed as local
reduced signal strength that appeared like a shadow with
diffuse borders within the retina extending into the choroid.
Figure 4 shows representative OCT images of eyes with a range
of cataracts from low to high grade. The shadow width and
intensity in the 3D 1060-nm OCT images were smaller than in
the 800-nm OCT images, and it was not located in the same
region.
In the 1060-nm OCT scans with good signal strength, the
retina, choroid, and the choroid interface with the sclera were
visible. There was no overall signal reduction in eyes with
dense cataracts (median of 3.5 units). With the 800-nm OCT,
the eyes with grades NO 3, NC 4, C 2.5, and P 4 were
imaged with a reduced signal strength. The three 1060-nm
OCT images with reduced signal strength had LOCS III grades
of NO5, NC6, C5, and P3; NO3, NC5, C3, and P5; and NO2,
NC4, C3, and P4.
The visual acuity of the subject with the densest cataract
(Fig. 5, subject 30), which had reduced signal strength on both
OCT instruments, was 0.34 log units. The visual acuity of the
other two subjects with reduced signal strength on the 3D
1060-nm OCT images were 0.5 log units (Fig. 5, subject 23)
and 0.3 log units (Fig. 5, subject 21).
DISCUSSION
In the present study, 3D 1060-nm OCT visualized the entire
depth of the choroid in an area larger than 30° in all imaged
eyes and without pupil dilation. Subsequent mapping of ChT
showed individual variation in ChT distribution among sub-
jects, and, when grouped, the variation was strongest on the
basis of AL. In individuals with mild, moderate, and dense
FIGURE 3. ChT in five different loca-
tions versus axial eye length. Trendlines
describe the negative statistical relation-
ship for all locations.
TABLE 2. Results of Statistical Testing of Choroidal Thickness Variation by Multiple Regression Analysis
All Eyes
(n  64)
Hyperopic Eyes
(n  28)
Emmetropic Eyes
(n  20)
Myopic Eyes
(n  16)
Factor R2 Factor R2 Factor R2 Factor R2
Central AL 0.43* ‡ 0.12 ‡ 0.21 AL, age 0.76†
Nasal AL 0.35* ‡ 0.17 ‡ 0.1 AL 0.55†
Temporal AL 0.41* AL 0.23† ‡ 0.27 AL 0.55†
Superior AL 0.44* ‡ 0.18 ‡ 0.21 AL 0.55†
Inferior AL 0.44* ‡ 0.04 ‡ 0.1 AL, age 0.85†
The factors axial eye length (AL), age, and sex were examined. First column: locations where ChT was measured. Column headings: groups
of eyes that were examined in the analysis. Only cells with significant models (significant R2 value) contain the contributing factor(s).
* P  0.001.
† P  0.05.
‡ No factor contributed to the model.
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cataracts, the 3D 1060-nm OCT was superior to an 800-nm
system in obtaining posterior pole images.
To date, wide area measurement of ChT with OCT at 800
nm has been conducted in myopic eyes14,16 with the subfoveal
choroid in these studies over a similar sized area being much
thinner than that in this study (100.5  56.9 m14 and 93.2 
62.5 m16). This difference is explainable by the inclusion of
patients with myopia of 6 D. The distribution at peripheral
choroidal positions was similar to that in the present study,
with the superior choroid being the thickest of all measure-
ments. However, results similar to those in the present study
have been found with high-resolution ultrasound imaging with
a mean ChT of 320 m in healthy eyes7 and, with 3D 1060-nm
OCT, of 354  111 m in Japanese subjects.19 In the latter
study,19 ChT was measured at five locations, and the inferior
choroid was thinner than the superior choroid. This finding is
in agreement with the mean of the representative ChT loca-
tions in all eyes in the present study, but a large individual
variation was observed. A correlation of central and inferior
ChT variation with age was found only in the group of longer,
myopic eyes. Instead, the overall ChT was characterized by AL.
Of all biometric parameters, AL correlates strongest with the
spherical equivalent and contributes to the other biometric
parameters of the eye.30 As well as a negative correlation of
ChT with higher ALs, a large ChT variation was displayed in the
coefficient of variation map of the longer, myopic eyes, per-
haps because of the inclusion of a larger range of ALs in the
data for the longer eyes, and may also be attributable to the
myopic eye shape. A study with a wide-field, high-resolution
scanning photorefractor, a system designed for the measure-
ment of the peripheral refraction, found that eye shape in
moderate myopia presents with more irregularity than in em-
metropia.31 The investigators hypothesized that this was due
to changes in the sclera and therefore was not detectable with
a commercial OCT. The sclera may be weaker in myopes with
a correlation between high myopia and scleral thinning found
in human eyes.32 The choroid adheres to the sclera because of
the fixed position of the blood vessels passing through the
sclera, and it is likely that the choroid is stretched and thins
after scleral changes in myopic eyes.33 Therefore, the present
study suggests ChT maps for a detailed investigation of the
entire field of view, although manual segmentation is suffi-
ciently time consuming to make its use in a clinical setting
difficult at present.
The present study revealed a decrease in ChT with age at
the central and inferior locations in eyes with the longer ALs
FIGURE 4. En face view and tomo-
grams generated from 3D 1060-nm OCT
and 800-nm OCT stacks from four sub-
jects with an increasing degree of cata-
ract and loss of image signal strength:
(A) NC1, NO2, C1.7, and P1; (B) NC3,
NO3, C2, and P1; (C) NC4, NO4.5, C5,
and P4; and (D) NC5, NO6, C5, and P3.
TABLE 3. LOCS III Classification of Cataract Images with Both Devices
LOCS III
Classification
All Eyes
(n  30)
800-nm OCT
3D 1060-nm-OCT Good Signal
Strength (n  27)
Good Signal Strength
(n  17)
Reduced Signal Strength
(n  13)
NO 3 (1–5) 3 (1–3) 3 (2–5) 3 (1–5)
NC 3.5 (2–6) 3 (2–4) 4 (3–6) 3.5 (2–5)
C 2 (1–5) 2 (1–2.5) 3 (2–5) 2 (1–5)
P 3 (1–5) 2 (1–4) 3.5 (1–5) 2 (1–5)
Data are expressed as the median (range).
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typically associated with myopia, which is in agreement with
the findings of other investigators.15,19 In contrast to these
results, it has been shown that with advancing age, the choroid
in mice thickens and morphologic age changes suggest cho-
roidal vascular inflammation with age.34 Visualization of ChT
and structure will be of special interest in the study of diseases
with suspected choroidal inflammation. At a molecular level,
choroidal inflammation has become the recent focus of inves-
tigation. Documentation of VAP-1, induced at sites of inflam-
mation,35 is found in both the retina and choroid arterial
vessels of the human eye.36 A sensitive, noninvasive in vivo
imaging device for investigating the structural change is useful
for inflammatory diseases affecting ocular vasculature, such as
diabetes, rheumatoid arthritis, and atherosclerosis.37 Experi-
mental findings of ocular inflammation demonstrate involve-
ment of all choroid layers. However, with 3D 1060-nm OCT,
the choriocapillaris is not discernible, as it is below the axial
resolution of the present 1060-nm instrument.38
Cataract affects image quality by reducing the signal-to-
noise ratio and therefore the signal strength of OCT at 800 nm
because of to light-scattering, and at present the only way to
improve the ratio is by removing the cataract.20 To our knowl-
edge, no other study has investigated the imaging performance
of 3D 1060-nm OCT in the posterior pole in patients with mild
to severe cataracts or compared it to the quality achieved with
800-nm OCT. In a study of 800-nm OCT, only moderate cata-
racts were included in evaluating OCT signal strengths.20 In a
previous study with moderate cataracts in which OCT at 800
nm failed, OCT at 1060 nm provided detail of the retinal and
choroidal structures irrespective of the opaque cataractous
lens.2 With a large range of cataract grades, image quality at
800 nm decreased with moderate to dense cataracts. The 1060
nm-3D-OCT acquired good-quality images with constant signal
strength in 27 eyes compared with only 17 with images of
good quality acquired by an 800-nm OCT. The en face visual-
ization of the stacks showed that areas of reduced signal
strength were smaller and did not overlap in 3D 1060-nm OCT
tomograms compared with the 800-nm OCT (Fig. 4, subject D).
Visualization of the posterior eye is crucial to patients’ clinical
management, especially in the presence of diabetes or ARMD.
Some participants in this study had secondary dense cataracts
due to other disease. Retinal health could not be monitored
accurately with any other technique, and cataracts were not
removed before the patient’s participation, because it was not
clear whether the patient would benefit. The results of this
study showed that the performance of 3D 1060-nm OCT can
be clinically useful in certain cases and that the visualization of
ChT was not affected by cataract density. It is possible that
extraneous factors, such as pupil margin artifacts or unstable
subject fixation, precluded the 3D 1060-nm OCT from obtain-
ing good-quality images with no reduction in signal strength in
a few of the cases. The LOCSIII does not specify the exact
location of cortical and posterior cataracts. The variation in the
spatial location of the cataract may explain why there was no
consistency in image quality and signal strength with the same
LOCS III grades.
In conclusion, this study establishes ChT distribution by
mapping, justifying the transverse resolution and visualization
of a large field of view of the 3D 1060-nm OCT with a contin-
uous measurement coverage. 3D high-speed 1060-nm OCT
enables retina and choroid visualization and choroidal quanti-
fication, resulting in ChT maps and a superior imaging ability in
dense cataracts, which cannot be achieved with any other
currently commercially available OCT technique. The litera-
ture shows potential involvement of the choroid in myopia,
ageing, and ocular diseases, but this notion has not been
sufficiently researched in vivo because of the lack of a com-
mercial high-resolution, 3D imaging device with choroid and
cataract penetration. Future 3D 1060-nm OCT studies of the
choroid’s characteristics in ocular abnormalities or diseases
should include an examination of axial length.
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